These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24962463)

  • 21. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the economic burden of MRSA in Germany].
    Claus F; Sachse A; Ried W
    Gesundheitswesen; 2014 Dec; 76(12):800-6. PubMed ID: 25372655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between visual acuity and medical and non-medical costs in patients with wet age-related macular degeneration in France, Germany and Italy.
    Bandello F; Augustin A; Sahel JA; Benhaddi H; Negrini C; Hieke K; Berdeaux GH;
    Drugs Aging; 2008; 25(3):255-68. PubMed ID: 18331076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Costs of schizophrenia - what we know (not)?].
    Salize HJ
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S21-8. PubMed ID: 11533903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Socio-economic impact of migraine and headaches in France].
    Auray JP
    CNS Drugs; 2006; 20 Spec no.1():37-46. PubMed ID: 16841525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and burden of headaches as assessed by the health family program.
    Silva Junior AA; Bigal M; Vasconcelos LP; Rodrigues J; Gomez RS; Krymchantowski AV; Moreira Filho P; Teixeira AL
    Headache; 2012 Mar; 52(3):483-90. PubMed ID: 22352696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed.
    Ayzenberg I; Katsarava Z; Sborowski A; Chernysh M; Osipova V; Tabeeva G; Steiner TJ
    Eur J Neurol; 2014 May; 21(5):758-65. PubMed ID: 24520863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence and indirect costs of headache in a Brazilian Company].
    Vincent M; Rodrigues Ade J; De Oliveira GV; De Souza KF; Doi LM; Rocha MB; Saporta MA; Orleans RB; Kotecki R; Estrela VV; De Medeiros VA; Borges WI
    Arq Neuropsiquiatr; 1998 Dec; 56(4):734-43. PubMed ID: 10029875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective.
    Effertz T; Engel S; Verheyen F; Linder R
    Eur J Health Econ; 2016 Dec; 17(9):1141-1158. PubMed ID: 26701837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On the socio-economic relevance of glaucoma].
    Grüb M; Rohrbach JM
    Klin Monbl Augenheilkd; 2006 Oct; 223(10):793-5. PubMed ID: 17063419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
    Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
    Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Atrial fibrillation in Germany: A prospective cost of illness study].
    Spyra A; Daniel D; Thate-Waschke IM; Berghaus S; Willich S; Zeymer U; Rychlik R
    Dtsch Med Wochenschr; 2015 Jul; 140(14):e142-8. PubMed ID: 26182263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of headache in Europe.
    Stovner LJ; Zwart JA; Hagen K; Terwindt GM; Pascual J
    Eur J Neurol; 2006 Apr; 13(4):333-45. PubMed ID: 16643310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economic impact of nocturia.
    Holm-Larsen T
    Neurourol Urodyn; 2014 Apr; 33 Suppl 1():S10-4. PubMed ID: 24729147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost of care and clinical condition in paediatric cystic fibrosis patients.
    Baumann U; Stocklossa C; Greiner W; von der Schulenburg JM; von der Hardt H
    J Cyst Fibros; 2003 Jun; 2(2):84-90. PubMed ID: 15463855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, burden, and cost of headache disorders.
    Stovner LJ; Hagen K
    Curr Opin Neurol; 2006 Jun; 19(3):281-5. PubMed ID: 16702836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany.
    Schreiber-Katz O; Klug C; Thiele S; Schorling E; Zowe J; Reilich P; Nagels KH; Walter MC
    Orphanet J Rare Dis; 2014 Dec; 9():210. PubMed ID: 25519771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007.
    Köster I; Huppertz E; Hauner H; Schubert I
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):377-85. PubMed ID: 21264804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.